Radiological findings of community-acquired methicillin-resistant and methicillin-susceptible Staphylococcus aureus pediatric pneumonia in Hawaii.
BACKGROUND
Community-acquired Staphylococcus aureus (CA-SA) infections are common among pediatric patients in Hawaii.


OBJECTIVE
We wanted to characterize the radiological features of methicillin-susceptible (CA-MSSA) and methicillin-resistant (CA-MRSA) staphylococcal pneumonia in Hawaiian children.


METHODS
We retrospectively reviewed medical records and imaging studies of children with SA pneumonia identified from 1996 through 2007.


RESULTS
Of 40 children, 26 (65%) had CA-MRSA pneumonia and 14 patients (35%) had CA-MSSA pneumonia. CA-MRSA patients were significantly younger than CA-MSSA patients (65% younger than 1 year vs. 36% older). In a majority (62%) of CA-MRSA patients, the consolidation was unilateral; in most of the CA-MSSA cases (79%), the consolidation was bilateral. Fifty percent of the patients with CA-MRSA and 21% of those with CA-MSSA had pneumatoceles (P = 0.1). CA-MRSA patients more commonly had pleural effusions (85% vs. 64% for CA-MSSA) and pleural thickening (50% vs. 36% for CA-MSSA).


CONCLUSIONS
This case series describes the radiologic characteristics of CA-MRSA and CA-MSSA pneumonia in children in a highly endemic area. We found that CA-MRSA pneumonias are unilateral in a majority of pediatric pneumonia cases, are more common in children 1 year or younger, and have higher rates of complications in comparison to CA-MSSA patients.
Erdem
Guliz
G
Department of Pediatrics, University of Hawaii, John A. Burns School of Medicine, 1319 Punahou St., Room 755, Honolulu, HI 96826, USA. guliz@hawaii.edu
Bergert
Lora
L
Len
Kyra
K
Melish
Marian
M
Kon
Kevin
K
DiMauro
Robert
R
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D017714:Community-Acquired Infections / Q000188:drug therapy / Q000453:epidemiology*; D005260:Female; D006254:Hawaii / Q000453:epidemiology; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D016106:Methicillin Resistance; D011023:Pneumonia, Staphylococcal / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000453:epidemiology*; D015995:Prevalence; D013902:Radiography, Thoracic / Q000706:statistics & numerical data*; D018570:Risk Assessment; D012307:Risk Factors; D013211:Staphylococcus aureus / Q000187:drug effects
Clin Infect Dis. 1999 Nov;29(5):1171-7
10524959
N Engl J Med. 2005 Apr 7;352(14):1436-44
15814879
MMWR Morb Mortal Wkly Rep. 2004 Aug 27;53(33):767-70
15329653
Med J Aust. 1996 Jun 17;164(12):721-3
8668078
J Infect Dis. 2008 Oct 15;198(8):1166-70
18729780
Emerg Infect Dis. 2005 Jun;11(6):966-8
15963299
Arch Intern Med. 2000 Apr 10;160(7):1001-4
10761966
Semin Respir Infect. 1994 Sep;9(3):199-206
7831542
Clin Infect Dis. 2003 Jan 15;36(2):131-9
12522744
Pediatrics. 2004 Jun;113(6):1735-40
15173499
Pediatr Infect Dis J. 2003 Jul;22(7):593-8
12867833
Pediatr Infect Dis J. 2001 Sep;20(9):860-3
11734764
N Engl J Med. 1995 Dec 14;333(24):1618-24
7477199
J Antimicrob Chemother. 2009 Sep;64(3):441-6
19608582
Clin Infect Dis. 2003 Jan 1;36(1):53-9
12491202
West J Med. 1978 Sep;129(3):201-9
706357
JAMA. 1998 Feb 25;279(8):593-8
9486753
Infect Control. 1982 Sep-Oct;3(5):377-83
6752075
Emerg Infect Dis. 2006 Jun;12(6):894-9
16707043
MMWR Morb Mortal Wkly Rep. 2007 Apr 13;56(14):325-9
17431376
JAMA. 2001 Sep 12;286(10):1201-5
11559265
Chest. 2005 Oct;128(4):2732-8
16236949
JAMA. 1999 Sep 22-29;282(12):1123-5
10501104
Ann Emerg Med. 2005 Nov;46(5):401-4
16271665
Pediatrics. 2004 Apr;113(4):e347-52
15060266
Infect Control Hosp Epidemiol. 2005 Feb;26(2):166-74
15756888
Pediatr Infect Dis. 1985 Nov-Dec;4(6):651-5
3853219
J Thorac Imaging. 2008 Feb;23(1):13-9
18347514
Infect Control Hosp Epidemiol. 2007 Mar;28(3):273-9
17326017
Lancet. 2002 Mar 2;359(9308):753-9
11888586
South Med J. 2005 Nov;98(11):1059-60
16351020
Pediatr Infect Dis J. 1999 Nov;18(11):993-1000
10571437
J Infect. 2007 Apr;54(4):349-57
16989904
Clin Infect Dis. 2005 Jan 1;40(1):100-7
15614698